patient protection News
-
Population diagnostics awarded two federal grants to support its autism and parkinson’s disease programs
Grant Awards – November 2, 2010 – Population Diagnostics was awarded two federal grants totaling $489,000 under a provision of the Patient Protection and Affordable Care Act enacted in 2010. The grant applications, which were reviewed and approved by the Department of Health and Human Services (HHS), are entitled: "Development of an Autism Early Detection Genetic Test" ...
-
Airsafe at Medica 2021 in Dusseldorf
We are pleased to inform that we will be present at MEDICA 2021 Exhibition, one of the world’s leading fair for the medical field will take place in Düsseldorf, from 15th to the 18th of November 2021. We welcome you at our booth, located at hall 17, where you can appreciate our Airsafe medical aerosol suction and filtration line includes mobile and centralized systems, designed to ...
By Airsafe
-
CARMAT receives final approval from the patient protection committee for the use of the commercial version of the Aeson heart in the EFICAS study in France
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that it has received final approval from the Patient Protection Committee (CPP Ile-de-France XI) for the use of the ...
By Carmat
-
In the Midst of a Pandemic, Why is the House of Representatives Trying to Undermine Biopharmaceutical Innovation?
Tom DiLenge, President, Advocacy, Law and Public Policy, of the Biotechnology Innovation Organization (BIO), released the following statement regarding the prescription drug provisions in the Patient Protection and Affordable Care Enhancement Act (HR 1425): “More than two-and-a-half million individuals across the country have been infected by the novel coronavirus and countless more have ...
-
CoPilot VL+ Video Laryngoscopy System COVID-19 RESPONSE
Dilon Technologies’ CoPilot VL+ video laryngoscopy system provides an excellent tool for intubating patients, especially those with suspected Covid-19 Coronavirus. The system’s handle and video monitor are separated by a five-foot cord allowing the monitor to be positioned at eye level, providing a clear visualization of the vocal cords while allowing the caregiver safer distancing ...
-
We are proud to announce that BioXtreme is awarded a R&D grant from the Israel Innovation Authority
We are proud to announce that BioXtreme was awarded a R&D grant from the Israel Innovation Authority (coupled with additional investment from our strategic investor) in the amount of $1M. The grant will be used to further develop and improve our groundbreaking solution, deXtreme, as well as develop a future finger grip product (either as a complementary product for deXtreme or an autonomous ...
-
SAVE LIVES: Clean your hands
On 5 May 2009, WHO formally launched its global initiative SAVE LIVES: Clean Your Hands as part of its First Global Patient Safety Challenge: 'Clean Care is Safer Care' 1 The aim of SAVE LIVES: Clean Your Hands is to continue to raise worldwide awareness about the importance of hand hygiene to prevent healthcare-associated infections and to sustain action to the point of patient care. More than ...
-
Praxair, Inc. Has Initiated a Voluntary Recall Affecting Grab ‘n Go® Vantage Portable Oxygen Cylinder Units
Praxair, Inc. (NYSE: PX) today announced that it is in the process of conducting a voluntary recall involving Grab ‘n Go Vantage portable oxygen cylinder units. Praxair is making a minor modification to the affected units as they come in for routine servicing and filling. Praxair has already communicated with its customers and the U.S. Food and Drug Administration. Praxair initiated this ...
-
BioXtreme Announces CE Marking
BioXtreme is proud to announce that, following our ISO-13485 certification from the Israeli Standards Institution (www.sii.org.il), it has received its CE Marking, based on self declaration. The CE Marking is intended for deXtreme, our upper limb neurorehabiliatation robotic device, meant to treat stroke and other TBI patients with our novel Error Enhancement technology. By this CE Marking we ...
-
BioXtreme strengthens management team with new sales manager
BioXtreme is happy to announce a new addition to its management team – Mrs. Tamar Moyal. Tamar will serve as the company’s Sales Manager and will be in charge of establishing sales operations in North America and Europe, including business development, contact with distributors, KOL’s, developing training materials and more. Tamar has more than 30 years of experience in sales ...
-
NOSA plugs launching in Canada
NOSA Plugs launching in Canada – the first discreet odour protection for healthcare professionals. Today, McArthur Medical Sales Inc. announced a new partnership with NOSA, as the sole distributor of NOSA Plugs, in Canada. “We’re proud to be partnering with such an innovative company and distributing a product that will improve the daily work for healthcare professionals across ...
-
Update regarding our Amyotrophic Lateral Sclerosis (ALS) study conducted at Sahlgrenska University Hospital in Gothenburg, Sweden
Our Phase IIa clinical trial evaluating the safety, tolerability and possible efficacy of subcutaneous injections of ILB® in ALS is finalized and has been reported to the Swedish Medical Products Agency. The results indicate that, for the variants of ALS and the given dose investigated in the study, ILB® seems to have beneficial clinical effects without significant side effects. A ...
By TIKOMED AB
-
In Recent Guidance, FDA aims for Patient Safety at 503B Facilities
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB) Healthcare Packaging explains: "A Dec. 10 statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram focused on the importance of ensuring compounded product quality. FDA noted that it continues to implement its 2018 Compounding Priorities Plan as part of its ...
-
Cedrec calls time on Working Time Directive
The European Commission's decision to review the Working Time Directive (WTD) has to be seen as a welcome opportunity to review legislation, conceived more than 20 years ago, in the light of fundamental changes to the economy, technology and working patterns says Neil Howe, senior legal author with online health and safety legislation specialists Cedrec. The WTD sets minimum standards on working ...
-
Cedrec calls time on Working Time Directive
The European Commission's decision to review the Working Time Directive (WTD) has to be seen as a welcome opportunity to review legislation, conceived more than 20 years ago, in the light of fundamental changes to the economy, technology and working patterns says Neil Howe, senior legal author with online health and safety legislation specialists Cedrec. The WTD sets minimum standards on ...
-
Hand Hygiene Day - Helping Health Workers Protect Patients with Clean Hands
In Ebola-affected countries, like Sierra Leone, the lack of running water can make hand hygiene a challenge. Hand hygiene is so important in public health that 5 May every year is marked as Hand Hygiene Day. Dr Komba Songu-Mbriwa is a doctor on the frontlines of the Ebola fight in Sierra Leone who also knows the challenges of the disease firsthand. He is an Ebola survivor. But today, he says his ...
-
STEPS Budapest Center for Robotic Rehabilitation to Install deXtreme 3.1 for Commercial Evaluation
BioXtreme is proud to announce that a new commercial evaluation agreement was signed with STEPS Budapest Center for Robotic Rehabilitation. The agreement includes a 6- months evaluation period for deXtreme, by the end of which STEPS commits to purchasing the device (pending evaluation criteria are met). BioXtreme has developed a ground-breaking robotic device for motor-learning, based on ...
-
Espoo Health Services chose Genano to protect patients and staff from viruses in the air
Espoo Health Services was well prepared for the expansion of the corona epidemic and reorganized its operations. One of the tasks was to change the Samaria health station in the center of Espoo, Finland, into an infection center focusing on the treatment of respiratory infections. In the next phase, another health station was prepared for similar use in case the first infection center's ...
-
Virometix announces initiation of Phase 1 clinical trial with its V-306 vaccine candidate
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, is pleased to announce that the Belgian health authority, FAMHP, has approved the company’s clinical trial application for the first-in-human phase 1 study of its respiratory syncytial virus (RSV) ...
By Virometix AG
-
Abbott rated one of the `best in class` companies for responsible citizenship
Abbott was named one of the top three 2010 Best in Class companies in its industry sector by Storebrand Investments, a leading Socially Responsible Investment (SRI) firm. Abbott"s Best in Class status is based on an evaluation of the financial, environmental and social performance of 15 companies in the pharmaceutical industry. Storebrand industry analyses begin with an initial selection of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you